TABLE 4.
Characteristic | Usual (n = 49) | Low (n = 9) | High (n = 8) | Total (n = 66) |
---|---|---|---|---|
Oral antibiotic agent | ||||
Amoxicillin | 12 (24.5%) | 0 | 5 (62.5%) | 17 (25.8%) |
Amoxicillin-clavulanate | 16 (32.7%) | 1 (11.1%) | 0 | 17 (25.8%) |
Cefadroxil | 7 (14.3%) | 3 (33.3%) | 2 (25.0%) | 12 (18.2%) |
Cefdinir | 9 (18.4%) | 0 | 1 (12.5%) | 10 (15.2%) |
Cephalexin | 1 (2.0%) | 4 (44.4%) | 0 | 5 (7.6%) |
Clindamycin | 1 (2.0%) | 1 (11.1%) | 0 | 2 (3.0%) |
Doxycycline | 1 (2.0%) | 0 | 0 | 1 (1.5%) |
Penicillin | 2 (4.1%) | 0 | 0 | 2 (3.0%) |
30-day treatment failure | 8 (16.3%) | 4 (44.4%) | 1 (12.5%) | 13 (19.7%) |
30-day mortality | 1 (2.0%) | 2 (22.2%) | 0 | 3 (4.5%) |
30-day readmission | 5 (10.2%) | 1 (11.1%) | 0 | 6 (9.1%) |
30-day relapse | 3 (6.1%) | 1 (11.1%) | 1 (12.5%) | 5 (7.6%) |
90-day treatment failure | 11 (22.4%) | 4 (44.4%) | 2 (25.0%) | 17 (25.8%) |
90-day mortality | 2 (4.1%) | 2 (22.2%) | 0 | 4 (6.1%) |
90-day readmission | 7 (14.3%) | 1 (11.1%) | 1 (12.5%) | 9 (13.6%) |
90-day relapse | 3 (6.1%) | 1 (11.1%) | 2 (25.0%) | 6 (9.1%) |